Category: United States
-
Federal Circuit decision in Optis v. Apple SEP case shows why UK courts should leave other jurisdictions alone: misconception exposed
In the seemingly neverending SEP story between Optis and Apple, the Federal Circuit has ordered a U.S. retrial on the merits and what would be a third damages trial in the same case.
-
Novartis and MSN settle part of chronic heart failure patent fight, but key patent remains
Novartis and MSN have settled one prong of their U.S. Entresto patent infringement dispute in the Federal Circuit, but the companies will continue to litigate over a second patent as Novartis strives to defend its corner of the chronic heart failure drug market.
-
Novo Nordisk lets key Ozempic patent lapse in Canada, despite being worldâs second-largest semaglutide market
Novo Nordisk has continued to pay for a key Ozempic patent in several jurisdictions across the world, and even obtained an adjusted expiration date in the U.S., but the company stopped paying fees in Canada as far back as 2018, records show.
-
Microsoft seeks declaratory judgment against Biogy over RFC one-time passcode patent in Northern District of California
Microsoft has alleged that Biogyâs prior âlitigation behaviorâ confirms it will be its next target in an RFC patent infringement suit.
-
USPTO on pace to quadruple discretionary denials under new interim procedures, report says
Recent data by Unified Patents has found that there were three times more United States Patent & Trademark Officeâs Patent Trial and Appeal Board discretionary denial decisions in Q1 2025 than the last record number of decisions (167 in 2020).
-
In U.S. court filing in ZTE case, Samsung raises “bias concerns” over Chinese FRAND proceedings: SEP-related sinophobia
Samsung just told a U.S. court it does not expect fairness from the Chinese courts because of the Chinese govenrment’s ownership position in ZTE.
-
Federal Circuit upholds Modernaâs win in COVID vaccine dispute against Alnylam
Alnylam acted as its own lexicographer in defining keywords in patent specifications, foreclosing its own infringement allegations against Moderna, the United States Court of Appeals for the Federal Circuit has ruled.
-
First-ever UPC Mannheim anti-antisuit injunction, U.S. court denies PI against Brazilian SEP enforcement: InterDigital v. Disney
This may even be the first anti-antisuit injunction ever to have been granted by a court based in the city of Mannheim, Germany.
-
ZTE moves for dismissal of Samsung’s California FRAND contract and antitrust action; filing reveals Samsung is seeking interim license in UK
ZTE has responded to Samsung’s SEP-related contract and antitrust complaint in the Northern District of California with a motion to dismiss.
-
Netflix aspires to become Broadcom’s Vietnam, amends second U.S. countersuit with two more patents
Not only has Netflix been defending against Broadcom’s cross-jurisdictional patent assertions for more than five years, but it’s now stepping up its retaliation.